Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

The St. Louis Post-Dispatch reports that the Missouri Department of Health and Senior Services awarded a no-bid contract to the Missouri Primary Care Association. The agreement will pay the organization $125,000 a year to focus on getting more adolescents to receive at least five vaccines, including influenza, hepatitis A and HPV. Contract talks began before health officials warned last week that a hepatitis A outbreak in the state could grow worse if it spreads to urban areas. Health officials say the state has recorded 414 cases of the virus since September 2017. In previous years, only about 10 cases were reported annually.
State awards contract to boost hepatitis A vaccination rate.

She's disappointed not to have been able to claim ultimate victory in the battle against the human immunodeficiency virus (HIV) that causes the killer disease AIDS, but also proud that in three decades, the virus has been beaten into check. While a cure for AIDS may or may not be found in her lifetime, the 68-year-old says, achieving "remission" - where infected patients control HIV in their bodies and, crucially, can come off treatment for years - is definitely within reach. "I am personally convinced that remission...is achievable. When? I don't know. But it is feasible," she told Reuters at her laboratory at Paris's Pasteur Institute, where she and her mentor Luc Montagnier discovered HIV in 1983. "We have 'proof of concept'. We have...the famous Visconti patients, treated very early on. Now it is more than 10 years since they stopped their treatment and they are still doing very well, most of them." Sinoussi is referring to a study group of 14 French patients known as the Visconti cohort, who started on antiretroviral treatment within 10 weeks of being infected and stayed on it for an average of three years. A decade after stopping the drugs, the majority have levels of HIV so low they are undetectable. These and other isolated cases of remission, or so-called "functional cure", give hope to the 37 million people worldwide who, due to scientific progress, should now be able to live with, not have their lives cut short by, HIV. In developed countries at least - and in many poorer ones too - an HIV positive diagnosis is no longer an immediate death sentence, since patients can enjoy long, productive lives in decent health by taking antiretroviral drugs to control the virus. It's a long way from the early 1980s, when Sinoussi remembers sick, dying HIV-positive patients coming to the doors of the Pasteur and pleading with scientists there for answers. "They asked us: 'What we are going to do to cure us'," she says. At that time, she says, she knew relatively little about HIV, but what she was sure of was that these patients would never live long enough to see a treatment developed, let alone a cure. "It was very, very hard." Yet this interaction with real patients, and with their doctors and later their advocates, gave Sinoussi an important insight into what was needed to make her life in science one with meaning and impact collaboration. Working across barriers - be they scientific disciplines, cultural, religious and political divides, international borders or gender distinctions, has been and remains Sinoussi's driving force. In her earliest days, feeling disengaged while working on her PhD and itching for action in a real-life laboratory, she hustled her way in to working at the male-dominated Pasteur Institute for free with a virologist researching links between cancers and retroviruses in mice. While viruses are her thing, she has throughout her career worked with, cajoled and learned from immunologists, cancer specialists, experts in diseases of aging, pharmaceutical companies, AIDS patients, campaigners, and even the pope. "When you work in HIV, it's not only working in HIV, it's working far, far beyond," she said. Freshly armed with her Nobel award and fired up about a lack of support for proven methods of preventing HIV's spread, Sinoussi wrote an open letter to then-Pope Benedict XVI in 2009 criticising him for saying that condoms can promote the spread of AIDS. In what was widely seen as a modification of his stance in response to such criticism, Benedict said in a book a year later that use of condoms could sometimes be justified in certain limited cases as a way to fight AIDS. Sinoussi says: "HIV has shown the way to go in the field of science. You can't be isolated in your laboratory. You need to work with others." And this, she adds, is the "all together" spirit with which she advises her successors to continue after she's gone. Many will be sad to see her leave, but she has faith that her chosen field will deliver for the people who need it. "Of course, I would love to have stopped and to see we had a vaccine against HIV and another treatment that could induce remission but that's life. I encourage the new generation of scientists today to continue our work. "Science never stops," she says. "Just because a scientist stops, the science should not stop."
Science won't stop until it beats AIDS, says HIV pioneer.

The case is the first in sub-Saharan Africa. Authorities fear the virus could spread quickly in a region where health systems are already overburdened with cases of malaria, measles, Ebola and other infectious diseases. Lagos, with 20 million people, is the biggest city in Nigeria, Africa's most populous country. The West African country, with a population of some 200 million people, has a shortage of doctors and hospitals are often poorly maintained. The Italian man works for cement company Lafarge Africa Plc (WAPCO.LG) in the southwestern state of Ogun, the company said in a statement. It said it had identified people who had "direct contact" with him before carrying out "isolation, quarantine and disinfection protocol." The Ogun state governor, in a separate media briefing, said 28 people had been placed in quarantine by the company the man worked for, although he did not mention it by name. The case has prompted a scramble by Nigerian authorities to try to "meet and observe" all passengers who arrived on the same flight as the man and to identify the places he visited before being hospitalized. "We have started working to identify all the contacts of the person since he entered Nigeria and even those who were with him on the aircraft," Health Minister Osagie Ehanire told reporters on Friday in the capital, Abuja. The Italian, whose country has been hit harder hit by the virus than any other in Europe, arrived on Feb. 24 on a Turkish Airlines flight that had a connection in Istanbul, said Lagos state commissioner for health, Akin Abayomi. After spending the night in a hotel near the airport, he went on Feb. 25 to his place of work in neighboring Ogun state, and stayed there until he developed a fever and body aches on the afternoon of Feb. 26, Abayomi told a news conference. He was then transferred to a high containment facility in Yaba, Lagos state. Ehanire said the infection was confirmed on Feb. 27 by the Virology Laboratory of the Lagos University Teaching Hospital, and that the man was now quarantined and doing well. Turkish Airlines did not immediately comment on the case. There are no confirmed cases in Turkey. Nigerian stocks fell 1.63% to their lowest level in two months on Friday following the announcement of the coronavirus case. The spread of the new coronavirus from China has hit global financial markets, and Nigeria's economy is at risk from the tumbling price of oil, which accounts for 90% of its foreign exchange earnings. The latest World Health Organization figures indicate over 82,000 people have been infected, with over 2,700 deaths in China and 57 deaths in 46 other countries. Officials from the Nigeria Centre for Disease Control (NCDC) are heading to Lagos to help address the case, and have activated its national Emergency Operations Centre. International health organization said they were working alongside their Nigerian counterparts. Africa Centres for Disease Control and Prevention (Africa CDC) said it is in contact with NCDC and is working with the WHO and other partners to support the Nigerian government's response. In a statement it said it had deployed one epidemiologist to Nigeria to support assessment and response to the outbreak, and has shipped 1,000 COVID-19 laboratory test kits to the country. And the WHO, which has said it already has experts in Nigeria, has identified Nigeria as one of 13 "high priority" countries in Africa. Dr Mike Ryan, executive director of WHO's emergencies program, told a Geneva news conference on Friday that Nigeria had "well-tested mechanisms for dangerous pathogens." He said Nigeria was able to utilize a laboratory network that had been developed to handle cases of Lassa fever, monkeypox and influenza. Schools and offices in Lagos provided hand sanitizer to people entering buildings on Friday. "There's a run on suppliers at the moment for hand sanitizer and masks," said Andrew Garza, chief operating officer of Lifestores Healthcare, a Lagos-based health technology company that provides inventory services to local pharmacies. Garza said some stockists had sold out of hand sanitizer.
Italian with coronavirus in Nigeria was not isolated for almost 48 hours.